Anumana, Inc. is one of 16099 FDA 510(k) medical device manufacturers from United States in the dataset, ranked by real submission volume.
Anumana, Inc. - FDA 510(k) Cleared Devices
Recent clearances: WatchMate Software, ECG-AI Cardiac Amyloidosis (CA) 12-Lead Algorithm (1040), ECG-AI Pulmonary Hypertension (PH) 12-Lead algorithm (1020)
Anumana, Inc. has 6 FDA 510(k) cleared medical devices. Based in Cambridge, US.
Latest FDA clearance: Jun 2026. Active since 2023. Primary specialty: Cardiovascular.
Browse the FDA 510(k) cleared devices submitted by Anumana, Inc. Filter by specialty or product code using the sidebar.
510(k) submissions have been managed by Veranex, Inc. as regulatory consultant. 1 device has linked clinical trial registered on ClinicalTrials.gov. 2 submissions have an FDA-authorized Predetermined Change Control Plan (PCCP), indicating AI or software-based device development.